Montelukast Prescribing at SCOTT PARK SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
182
Total Quantity
5,124
NHS Cost
£296
vs National Avg
-73.4%
SCOTT PARK SURGERY prescribed 182 items of Montelukast over the last 12 months at a cost of £296 to the NHS. This is 73.4% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
15
Jul 2026
12
Jul 2026
14
Jul 2026
15
Jul 2026
16
Jul 2026
17
Jul 2026
16
Jul 2026
16
Jul 2026
17
Jul 2026
13
Jul 2026
15
Jul 2026
16
Prescribing Details
| Total Items | 182 |
|---|---|
| Total Quantity | 5,124 |
| Total NHS Cost | £296 |
| Presentations | 3 different forms |
| vs National Average | -73.4% |
Montelukast Prescribing Comparison
| This practice | 182 items |
|---|---|
| National average per practice | 685 items |
| Difference | -73.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.